196 related articles for article (PubMed ID: 15791618)
1. Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP/ABCB11.
Hayashi H; Takada T; Suzuki H; Akita H; Sugiyama Y
Hepatology; 2005 Apr; 41(4):916-24. PubMed ID: 15791618
[TBL] [Abstract][Full Text] [Related]
2. 4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps.
Hayashi H; Sugiyama Y
Hepatology; 2007 Jun; 45(6):1506-16. PubMed ID: 17538928
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic differences in PFIC2 and BRIC2 correlate with protein stability of mutant Bsep and impaired taurocholate secretion in MDCK II cells.
Kagawa T; Watanabe N; Mochizuki K; Numari A; Ikeno Y; Itoh J; Tanaka H; Arias IM; Mine T
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G58-67. PubMed ID: 17947449
[TBL] [Abstract][Full Text] [Related]
4. Short-chain ubiquitination is associated with the degradation rate of a cell-surface-resident bile salt export pump (BSEP/ABCB11).
Hayashi H; Sugiyama Y
Mol Pharmacol; 2009 Jan; 75(1):143-50. PubMed ID: 18829893
[TBL] [Abstract][Full Text] [Related]
5. Levels of plasma membrane expression in progressive and benign mutations of the bile salt export pump (Bsep/Abcb11) correlate with severity of cholestatic diseases.
Lam P; Pearson CL; Soroka CJ; Xu S; Mennone A; Boyer JL
Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1709-16. PubMed ID: 17855769
[TBL] [Abstract][Full Text] [Related]
6. The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II.
Wang L; Soroka CJ; Boyer JL
J Clin Invest; 2002 Oct; 110(7):965-72. PubMed ID: 12370274
[TBL] [Abstract][Full Text] [Related]
7. Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis.
Noe J; Kullak-Ublick GA; Jochum W; Stieger B; Kerb R; Haberl M; Müllhaupt B; Meier PJ; Pauli-Magnus C
J Hepatol; 2005 Sep; 43(3):536-43. PubMed ID: 16039748
[TBL] [Abstract][Full Text] [Related]
8. Discovery and structural development of small molecules that enhance transport activity of bile salt export pump mutant associated with progressive familial intrahepatic cholestasis type 2.
Misawa T; Hayashi H; Sugiyama Y; Hashimoto Y
Bioorg Med Chem; 2012 May; 20(9):2940-9. PubMed ID: 22464344
[TBL] [Abstract][Full Text] [Related]
9. Short- and medium-chain fatty acids enhance the cell surface expression and transport capacity of the bile salt export pump (BSEP/ABCB11).
Kato T; Hayashi H; Sugiyama Y
Biochim Biophys Acta; 2010 Sep; 1801(9):1005-12. PubMed ID: 20398791
[TBL] [Abstract][Full Text] [Related]
10. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families.
Strautnieks SS; Byrne JA; Pawlikowska L; Cebecauerová D; Rayner A; Dutton L; Meier Y; Antoniou A; Stieger B; Arnell H; Ozçay F; Al-Hussaini HF; Bassas AF; Verkade HJ; Fischler B; Németh A; Kotalová R; Shneider BL; Cielecka-Kuszyk J; McClean P; Whitington PF; Sokal E; Jirsa M; Wali SH; Jankowska I; Pawłowska J; Mieli-Vergani G; Knisely AS; Bull LN; Thompson RJ
Gastroenterology; 2008 Apr; 134(4):1203-14. PubMed ID: 18395098
[TBL] [Abstract][Full Text] [Related]
11. A progressive familial intrahepatic cholestasis type 2 mutation causes an unstable, temperature-sensitive bile salt export pump.
Plass JR; Mol O; Heegsma J; Geuken M; de Bruin J; Elling G; Müller M; Faber KN; Jansen PL
J Hepatol; 2004 Jan; 40(1):24-30. PubMed ID: 14672610
[TBL] [Abstract][Full Text] [Related]
12. Degradation of the bile salt export pump at endoplasmic reticulum in progressive familial intrahepatic cholestasis type II.
Wang L; Dong H; Soroka CJ; Wei N; Boyer JL; Hochstrasser M
Hepatology; 2008 Nov; 48(5):1558-69. PubMed ID: 18798335
[TBL] [Abstract][Full Text] [Related]
13. Clinical phenotype and molecular analysis of a homozygous ABCB11 mutation responsible for progressive infantile cholestasis.
Imagawa K; Hayashi H; Sabu Y; Tanikawa K; Fujishiro J; Kajikawa D; Wada H; Kudo T; Kage M; Kusuhara H; Sumazaki R
J Hum Genet; 2018 May; 63(5):569-577. PubMed ID: 29507376
[TBL] [Abstract][Full Text] [Related]
14. Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing.
Byrne JA; Strautnieks SS; Ihrke G; Pagani F; Knisely AS; Linton KJ; Mieli-Vergani G; Thompson RJ
Hepatology; 2009 Feb; 49(2):553-67. PubMed ID: 19101985
[TBL] [Abstract][Full Text] [Related]
15. Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency.
Felzen A; van Wessel DBE; Gonzales E; Thompson RJ; Jankowska I; Shneider BL; Sokal E; Grammatikopoulos T; Kadaristiana A; Jacquemin E; Spraul A; Lipiński P; Czubkowski P; Rock N; Shagrani M; Broering D; Nicastro E; Kelly D; Nebbia G; Arnell H; Fischler B; Hulscher JBF; Serranti D; Arikan C; Polat E; Debray D; Lacaille F; Goncalves C; Hierro L; Muñoz Bartolo G; Mozer-Glassberg Y; Azaz A; Brecelj J; Dezsőfi A; Calvo PL; Grabhorn E; Hartleif S; van der Woerd WJ; Kamath BM; Wang JS; Li L; Durmaz Ö; Kerkar N; Jørgensen MH; Fischer R; Jimenez-Rivera C; Alam S; Cananzi M; Laverdure N; Ferreira CT; Guerrero FO; Wang H; Sency V; Kim KM; Chen HL; de Carvalho E; Fabre A; Bernabeu JQ; Zellos A; Alonso EM; Sokol RJ; Suchy FJ; Loomes KM; McKiernan PJ; Rosenthal P; Turmelle Y; Horslen S; Schwarz K; Bezerra JA; Wang K; Hansen BE; Verkade HJ;
JHEP Rep; 2023 Feb; 5(2):100626. PubMed ID: 36687469
[TBL] [Abstract][Full Text] [Related]
16. Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate.
Gonzales E; Grosse B; Schuller B; Davit-Spraul A; Conti F; Guettier C; Cassio D; Jacquemin E
Hepatology; 2015 Aug; 62(2):558-66. PubMed ID: 25716872
[TBL] [Abstract][Full Text] [Related]
17. Functional rescue of an ABCB11 mutant by ivacaftor: A new targeted pharmacotherapy approach in bile salt export pump deficiency.
Mareux E; Lapalus M; Amzal R; Almes M; Aït-Slimane T; Delaunay JL; Adnot P; Collado-Hilly M; Davit-Spraul A; Falguières T; Callebaut I; Gonzales E; Jacquemin E
Liver Int; 2020 Aug; 40(8):1917-1925. PubMed ID: 32433800
[TBL] [Abstract][Full Text] [Related]
18. Taurocholate transport by hepatic and intestinal bile acid transporters is independent of FIC1 overexpression in Madin-Darby canine kidney cells.
Harris MJ; Kagawa T; Dawson PA; Arias IM
J Gastroenterol Hepatol; 2004 Jul; 19(7):819-25. PubMed ID: 15209631
[TBL] [Abstract][Full Text] [Related]
19. Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2.
Gonzales E; Grosse B; Cassio D; Davit-Spraul A; Fabre M; Jacquemin E
J Hepatol; 2012 Sep; 57(3):695-8. PubMed ID: 22609309
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of the correlation between ABCB11 gene mutation and primary intrahepatic stone.
Gan L; Pan S; Cui J; Bai J; Jiang P; He Y
Mol Med Rep; 2019 Jan; 19(1):195-204. PubMed ID: 30431138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]